We create unparalleled partnerships with our clients to develop life-changing therapeutics, tests, and processes to support our mission of saving lives through enhanced patient care.
Through our expertise, customization, and scalability, NeoGenomics supports clients in cancer-related market segments, including hospital and private pathology laboratories, office-based oncologists, academic institutions, contract research and pharmaceutical development organizations, and more. We are tirelessly pushing the boundaries and improving our capabilities to provide our partners with the most technologically advanced testing available, integrating the latest clinical evidence and guidelines to advance the care of all patients.
- Leadership
- Board of Directors
- Medical & Scientific
- Scientific Advisory Board
Medical and Scientific Leadership Team
Hematopathologists
Surgical Pathologists
Molecular Pathologists
Pharma Services Pathologists
Scientific Team Members
The NeoGenomics Scientific Advisory Board
At NeoGenomics, innovation is one of our core values to ensure we provide one of the most comprehensive oncology-focused testing menus in the world. Our Scientific Advisory Board is a dedicated group of international leaders who deeply understand NeoGenomics’ current services and future potential and are committed to being insightful advisors to support our mission of saving lives through enhanced patient care.
Due to their institution’s regulations, select members of our Scientific Advisory Board cannot be listed.